Overview of Peptide Stability
Peptide stability is a critical parameter in pharmaceutical research and development. Degradation pathways including hydrolysis, oxidation, and aggregation can significantly impact compound integrity and research reproducibility.
Primary Degradation Pathways
Hydrolytic Degradation
Peptide bonds are susceptible to hydrolysis, particularly at Asp-Pro and Asp-Gly sequences. Research protocols typically assess stability across pH ranges of 4.0–8.0 at temperatures of 4°C, 25°C, and 40°C.
Oxidative Degradation
Methionine, cysteine, and tryptophan residues are particularly vulnerable to oxidative stress. Accelerated stability studies expose compounds to hydrogen peroxide (0.1–3%) and controlled light exposure per ICH Q1B guidelines.
Physical Instability
Aggregation and fibrillation represent significant challenges for injectable peptide formulations. Dynamic light scattering (DLS) and size-exclusion chromatography (SEC) are standard analytical methods.
ICH Stability Guidelines
ICH Q1A(R2)
Guidelines require long-term stability data at 25°C/60% RH for a minimum of 12 months
The International Council for Harmonisation (ICH) Q1A(R2) guidelines provide the framework for stability testing of drug substances and products intended for registration.
Analytical Methods
Key analytical techniques in peptide stability research:
- —RP-HPLC: Primary method for purity assessment and degradation product quantification
- —Mass Spectrometry: Identification of degradation products and structural modifications
- —CD Spectroscopy: Secondary structure assessment
- —Karl Fischer Titration: Moisture content determination
Formulation Strategies
Lyophilization (freeze-drying) remains the gold standard for long-term peptide storage in research settings, achieving moisture content below 1% and enabling storage at room temperature for extended periods.